Stempeutics' Stempeucel gets Orphan Drug status in Europe
Shares of Cipla were trading at Rs 669.05 per scrip in the afternoon trade on BSE, up 2.86 percent from its previous close.
Jun 01, 2015, 14:31 PM IST
Cipla to acquire 51% stake in Uganda's Quality Chemicals
Cipla shares today ended at Rs 674.05 apiece on the BSE, down 0.05 percent from previous close.
May 22, 2015, 17:33 PM IST
Cipla recalls over 1.4 lakh vials of asthma drug in US
Drug major Cipla is recalling in the US market 1,40,625 vials of Levalbuterol Inhalation Solution used for relieving shortness of breath and coughing caused by asthma and chronic obstructive pulmonary disease.
May 21, 2015, 16:04 PM IST
Cipla promoters to decide on family pact in 'due course'
Sebi has opined that the agreement would qualify for exemption from open offer requirement under takeover norms.
May 10, 2015, 12:16 PM IST
Cipla promoter family gets SEBI go-ahead for voting agreement
In a possible succession planning exercise, pharma giant Cipla's promoter family has proposed to vote together as a single unit under overall direction of patriarch Yusuf Hamied in his lifetime, and under his brother Mustafa Hamied thereafter.
May 05, 2015, 23:13 PM IST
Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC
Indian pharma firm Cipla Monday suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could serve 66,000 patients in India at a cheaper rate.
Apr 27, 2015, 23:21 PM IST
Cipla to acquire Brazil's Duomed Produtos for Rs 2.6 crore
Pharma major Cipla on Thursday said its UK subsidiary Cipla (EU) will acquire Brazilian firm Duomed Produtos Farmaceuticos for about Rs 2.6 crore.
Apr 09, 2015, 11:42 AM IST
Cipla to launch generic Hepatitis C drug 'Hepcvir' in India
Drug major Cipla on Wednesday announced the launch of generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name 'Hepcvir', in India.
Mar 25, 2015, 15:37 PM IST
Cipla to form JV with Biopharm SPA for respiratory products
Pharmaceutical firm Cipla Ltd has entered into an agreement with Biopharm SPA to form a joint venture company in Algeria to manufacture and market respiratory products, the company said Friday.
Feb 13, 2015, 12:25 PM IST
Cipla forms JV in Morocco to enhance position in African market
Cipla (EU) Ltd, UK, a wholly-owned subsidiary of Mumbai-based drug firm, has inked the JV agreement with the Moroccan entities.
Feb 09, 2015, 18:56 PM IST
Hamied family co buys out minority shareholders in Okasa
Hamsons, a firm owned by the promoter family of pharma major Cipla, has bought out the remaining 21 per cent equity owned by minority shareholders in Satara-based Okasa Pharma for an undisclosed amount, completing the process it started last September.
Jan 14, 2015, 21:55 PM IST
Cipla moves HC against restraint on its Indacaterol-based drug
The matter was mentioned before a bench of Justices Badar Durrez Ahmed and Sanjeev Sachdeva who directed that the plea be listed before the appropriate bench tomorrow.
Jan 13, 2015, 18:24 PM IST
HC restrains Cipla from selling drug containing Indacaterol
The court said the restraint on Cipla will remain till its application for compulsory license is decided by the relevant authority.
Jan 09, 2015, 23:51 PM IST
HC order 'disappointing', says Cipla
Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.
Jan 09, 2015, 23:10 PM IST
Cipla among winners in $860 million South Africa aids drug tender
Aspen Pharmacare was awarded a 2.5 billion contract, India`s Cipla a 2 billion deal, US-based Mylan won a 2.8 billion share and unlisted local firm Sonke got a 3 billion stake in the tender.
Dec 24, 2014, 20:57 PM IST
Cipla's arm Meditab sells stake in Jiangsu for $18.5 mn
The closing of the transaction is subject to receipt of applicable regulatory approvals in China, it added.
Dec 10, 2014, 14:39 PM IST
Meda and Cipla sue Apotex to enforce Dymista patents
Sweden-based drug firm Meda Pharmaceuticals Inc and Cipla Ltd have "sued" Apotex Inc and Apotex Corp in Federal District Court in Delaware in US to enforce patents of its allergy drug 'Dymista'.
Dec 03, 2014, 14:52 PM IST
Cipla shares up nearly 4%
Shares of pharmaceuticals firm Cipla today rose by nearly 4 percent after it announced an agreement with Serum Institute of India for distribution of paediatric vaccines in Europe.
Nov 20, 2014, 18:26 PM IST
Cipla-Novartis patent row: DIPP looking into merit of case
The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access.
Nov 02, 2014, 11:51 AM IST
Cipla asks govt to revoke Novartis' patent; launches its drug
Taking the patent battle to Novartis, India's Cipla has launched low-cost generic version of the Swiss drug maker's respiratory drug Indacaterol sold under the Onbrez brand, while asking the government to revoke patents over the medicine.
Oct 30, 2014, 19:02 PM IST
